Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling Pathway
The FASEB Journal · 2025
DOI: 10.1096/fj.202500281r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Julia Moellmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany. Hauptthemen laut MEDLINE: Cardiomyopathies, Uremia, Signal Transduction, Disease Models, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mech Sharp and Dohme Germany, Deutsche Forschungsgemeinschaft, Interreg V-A grant EURlipids.
Abstract (Originalsprache)
Patients with chronic kidney disease are at an increased risk of developing heart failure, but the underlying mechanisms remain incompletely understood, at least in part because of the paucity of mouse models of uremic cardiomyopathy. In this study, we used two different experimental setups of 2,8‐dihydroxyadenine‐induced nephropathy in different mouse strains to develop a non‐invasive mouse model of uremic cardiomyopathy. Among the different models, only 129/Sv mice fed an adenine‐supplemented diet for 16 weeks showed typical features of uremic cardiomyopathy. Kidney damage was confirmed by histopathologic findings of diffuse fibrosis with collagen deposition, crystal formation, and uremia. The cardiac phenotype showed significantly increased myocardial fibrosis associated with impaired cardiac contractility under dobutamine‐induced stress conditions. This was associated with a significant activation of the mTOR pathway and downstream endoplasmic reticulum stress, increased apoptosis, and inflammation. Treatment of 129/Sv mice with an adenine‐supplemented diet for 16 weeks represents a model of uremic cardiomyopathy with increased myocardial fibrosis and impaired cardiac function, as well as a shift from cardioprotective to detrimental signaling, increased endoplasmic reticulum stress, and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
- Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
- Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.
- Department of Nephrology, RWTH Aachen University, Aachen, Germany.
ORCID-Profile: Julia Moellmann, Barbara M Klinkhammer, Peter Boor
Förderung
- Mech Sharp and Dohme Germany
- Deutsche Forschungsgemeinschaft
- Interreg V-A grant EURlipids
- Deutsche Herzstiftung (German Heart Foundation)
- CORONA Stiftung
- Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University
- Ernst und Berta Grimmke Stiftung
- H2020 European Reaserch Council
Zitieren
APA
Moellmann, J., Glandien, K., Klinkhammer, B. M., Wollenhaupt, J., Noels, H., Jankowski, J., Lebherz, C., Boor, P., Lehrke, M., & Marx, N. (2025). Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling Pathway. The FASEB Journal. https://doi.org/10.1096/fj.202500281r
Vancouver
Moellmann J, Glandien K, Klinkhammer BM, Wollenhaupt J, Noels H, Jankowski J, et al. Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling Pathway. The FASEB Journal. 2025. doi:10.1096/fj.202500281r
BibTeX
@article{Moellmann2025,
author = {Moellmann, Julia and Glandien, Katja and Klinkhammer, Barbara M and Wollenhaupt, Julia and Noels, Heidi and Jankowski, Joachim and Lebherz, Corinna and Boor, Peter and Lehrke, Michael and Marx, Nikolaus},
title = {Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling Pathway},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500281r}
}
EUVIMED